Proficiency testing (PT) is a critical quality assurance tool that ensures laboratory accuracy and reliability by comparing test results with established standards. Improper handling of PT—especially through unauthorized referral to external labs—can lead to regulatory sanctions, making it essential for lab directors, supervisors, and staff to understand and comply with PT referral rules.

Dr. Bill Morice shares how clinical diagnostics are expanding to guide treatment and enable clinicians to target therapies more precisely.

Accurate coagulation testing starts with proper specimen preparation. Even small pre-analytic errors, such as underfilled tubes, hemolysis, or improper centrifugation, can compromise results and patient care.

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, welcomes William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories. Together, they discuss recent news about virus activity and explore the value of collaboration in shaping innovative diagnostic strategies.

Recognize the motivations and barriers of first-time blood donors and work to retain them for sustainable future donations.

Mayo Clinic Laboratories' specimen pickup and delivery schedules will be altered due to the upcoming Thanksgiving holiday. To ensure specimen stability and prevent delays, follow the guidelines outlined below for domestic clients and international clients.

In this episode of the “Leveraging the Laboratory” podcast, Jane Hermansen, outreach manager at Mayo Clinic Laboratories, is joined by Todd Juen, outpatient lab supervisor at Mayo Clinic. Together, they explore how to deliver exceptional experiences to patient populations with unique needs.

A refreshed format of Mayo Clinic Laboratories’ “Answers From the Lab” podcast allows us to deliver even more valuable insights to listeners.

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, to discuss recent news about drug-resistant infections. Later, Paul Jannetto, Ph.D., director of the Clinical and Forensic Toxicology Lab, Clinical Mass Spectrometry Lab, and Metals Lab, joins Dr. Pritt for the deep dive segment. Together, they explore how diagnostics are shaping the future of therapeutics.

Discover a checklist designed to help you create a positive experience that makes your lab patients’ preferred destination for laboratory services.

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, and William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, discuss recent regulatory and policy developments.

Register now – Dec. 10, 2025 - This webinar explores the rapidly evolving field of pharmacogenomics, with a special focus on the DPYD gene and its significance in oncology.

In the third quarter of 2025, Mayo Clinic Laboratories expanded its test catalog with several innovative new tests.

This microlearning will familiarize users on MCL's AI-augmented kidney stone test along with the proper procedures for collecting and processing kidney stones to provide accurate, cost-effective, and timely analysis of the stones.

Artificial intelligence (AI) is reshaping laboratory medicine, not as a distant promise, but as a practical tool improving diagnostics, workflows, and quality. Through collaborative development, rigorous validation, and a commitment to ethical innovation, Mayo Clinic Laboratories is implementing AI-driven solutions that enhance precision, reduce turnaround times, and empower laboratorians to focus on what matters most: patient care.